Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Total Non-Current Liabilities (2022 - 2026)

HeartSciences filings provide 5 years of Total Non-Current Liabilities readings, the most recent being $633481.0 for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 83.17% to $633481.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $633481.0, a 83.17% increase, with the full-year FY2025 number at $314527.0, down 27.54% from a year prior.
  • Total Non-Current Liabilities hit $633481.0 in Q1 2026 for HeartSciences, up from $247263.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $4.7 million in Q2 2022 to a low of $247263.0 in Q4 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $518056.0 (2022), compared with a mean of $945389.2.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 73.82% in 2023 and later skyrocketed 83.17% in 2026.
  • HeartSciences' Total Non-Current Liabilities stood at $549227.0 in 2022, then dropped by 11.35% to $486885.0 in 2023, then decreased by 5.97% to $457814.0 in 2024, then crashed by 45.99% to $247263.0 in 2025, then skyrocketed by 156.2% to $633481.0 in 2026.
  • The last three reported values for Total Non-Current Liabilities were $633481.0 (Q1 2026), $247263.0 (Q4 2025), and $281570.0 (Q3 2025) per Business Quant data.